Changchun Discovery Sciences, Ltd.

Changchun Discovery Sciences, Ltd. (长春吉大天元化学技术股份有限公司) was founded in 2000 as a research-oriented joint-stock company established with investment from Jilin Jida Holding Co., Ltd., Changchun Science and Technology Development Center Co., Ltd., Changchun Science and Technology Venture Capital Co., Ltd., Changchun Entrepreneurship Technology Development Co., Ltd., and overseas-returned students. With Jilin University as its technology and innovation support, the company focuses on combinatorial chemistry synthesis as a key technology in new drug discovery, and aims to provide technical services and talent development in the drug-creation field. Its main business includes the design and synthesis of small-molecule drugs, process development for innovative and generic drugs, peptide compound synthesis, health product R&D, consulting services, and analytical testing. Dr. Bai Xu is the founder and chairman.

Changchun Discovery Sciences, Ltd. was founded in 2000 as a research-oriented joint-stock company established with investment from Jilin Jida Holding Co., Ltd., Changchun Science and Technology Development Center Co., Ltd., Changchun Science and Technology Venture Capital Co., Ltd., Changchun Entrepreneurship Technology Development Co., Ltd., and overseas-returned students. The company uses Jilin University as its technology and innovation support and focuses on combinatorial chemistry synthesis as a key technology in new drug discovery, with the goal of providing technical services and talent development in the drug-creation field. Over the years it has received honors including a key innovation team award from the Overseas Chinese Affairs Office of the State Council and National High-tech Enterprise status, and it passed evaluation by the Jilin Provincial Department of Science and Technology and was authorized to establish the 'Jilin Province Combinatorial Chemistry Technology Innovation Center.'

Research-oriented joint-stock company integrating industry, academia, and research, supported by Jilin University and focused on combinatorial chemistry synthesis for new drug discovery.

• Inhibitors/receptor agonists

  Product category listed on the company website.

• Intermediates

  Product category listed on the company website.

• Compound libraries

  Representative compound library products supplied in mg quantities, totaling 7,450 compounds.

• Peptide compounds

  Peptide compound synthesis service; example includes exenatide synthesis with purity greater than 99%.

1. 1长春吉大天元化学技术股份有限公司jdty.com
2. 2公司简介 - 关于我们 - 长春吉大天元化学技术股份有限公司jdty.com
3. 3公司简介 - 关于我们 - 长春吉大天元化学技术股份有限公司jdty.com
4. 4定制服务 - 长春吉大天元化学技术股份有限公司jdty.com